Mergers & Acquisitions Mergers & Acquisitions

UnitedHealth-Change Healthcare deal must be blocked to prevent 'real monopoly’ in health insurance, DOJ tells US judge

By Khushita Vasant
  • 01 Aug 2022 21:25
  • 01 Aug 2022 21:51
An injunction is the only remedy against anticompetitive effects that would emerge from UnitedHealth Group’s proposed $13 billion acquisition of Change Healthcare, as the deal will result in a “real monopoly” and harms competition, the US Department of Justice told a federal court judge.
Counsel for the DOJ told US

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Khushita Vasant

Chief Antitrust Correspondent, US


Khushita covers US antitrust enforcement and litigation for MLex. A former Brussels hand, she wrote about about antitrust & mergers for the Policy and Regulatory Report (PaRR), she has covered the EU's actions against Google, Apple, Facebook and Amazon to name a few. Khushita specialises in tech and patent policy coverage which featured in the Concurrences Antitrust Writing Awards. Previously as a financial journalist for The Wall Street Journal and Dow Jones Newswires, she wrote about monetary policy and the bond and currency markets. Khushita studied journalism at Mumbai University, and received an Erasmus Mundus scholarship for a masters from universities in Germany and Austria.

Discover MLex

Stay on top of global regulatory developments

Latest News